Press Room

News / Oct 19, 2021

Hovione website wins Digital Communication Awards 2021!

Hovione.com wins GOLD for the best website in the Digital Communication Awards 2021

Hovione website wins Digital Communication Awards DCA 2021

? Hovione wins Best Website Award ?







 

DCA Hovione wins Award - Gold Winner 2021 for Best Website

 

Our website www.hovione.com has been distinguished with the Digital Communication Awards that reward outstanding online projects and campaigns.

 

Our website was ranked as one of the best of over 400 applications and was chosen as a GOLD winner by the jury members in the website category.

 

The new website project that was launched in February 2021 and was described as “100% responsive with a personalized, clean, vibrant design and it is also more inclusive. The content is accessible to visually impaired people who can understand visual content."

 

The new website also presents a chatbot that is ready to answer the first questions in a faster and trendy way. It helps to get closer and provide a better customer experience. The website is user-friendly and lives by our motto - In it for life.

Hovione.COM New Website

The Digital Communication Awards are open to companies and agencies, associations and NGOs, political institutions, and parties from all over the globe since 2011.

 

 

Learn more and find the full list of winners at Digital-Awards.eu









 

Also in the Press Room

See All

Integrated approach simplifies development, reduces risk, and supports scalable manufacturing. Hovione and Industrial Design Consultancy Ltd.’s (IDC) lead single-use nasal dry powder device is now available for commercial partnerships. Hovione and IDC have completed the device design and established initial device manufacturing and supply capability, enabling pharmaceutical partners to leverage existing capsule filling infrastructure. This approach simplifies development, reduces cost and risk, and helps shorten timelines to the clinic and commercialization. “This milestone marks an important step in the evolution of our collaboration with IDC — from device innovation to a fully integrated intranasal drug delivery platform,” said Márcio Temtem, Ph.D., Vice President, Strategic Business Management, Hovione. “As the industry looks for faster, more reliable ways to bring complex therapies to patients, integration becomes critical. By bringing together nasal particle engineering science, formulation manufacturing and filling, and device technologies into a single offering, we enable a more seamless and predictable development journey, accelerating the path to market for intranasal therapies.” The nasal delivery device enables broad and targeted nasal deposition flexibility while delivering maximum usability and reliability. With a patented design and manufacturing process established, the platform is available for partnering with pharmaceutical companies on an exclusive basis as part of Hovione’s integrated offering for inhalation and nasal drug development and manufacturing. Additionally, IDC’s Managing Director, Stephen Knowles Ph.D., said the companies are now “well-advanced” with the development of a multi-use device to support an even wider range of therapies and patient needs. Read the full article at ContractPharma.com    

Press Clipping

Hovione, IDC Launch Intranasal Drug Delivery Platform

May 07, 2026